Pharma Co. Reports Positive Data for Leukemia Combination Therapy
Pharma Co. Reports Positive Data for Leukemia Combination Therapy
Stay updated with breaking news from Andrew Fein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharma Co. Reports Positive Data for Leukemia Combination Therapy
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported upbeat earnings for its third quarter, while sales missed estimates.
In a report released today, Andrew Fein from H.C. Wainwright maintained Merus (MRUS – Research Report) to a Buy, with a price target of $4...
Tuesday, the FDA lifted the clinical hold on Fulcrum Therapeutics Inc's FULC Investigational New Drug (IND) application for FTX-6058 for the potential…
Tuesday, the FDA lifted the clinical hold on Fulcrum Therapeutics Inc's (NASDAQ: FULC) Investigational New Drug (IND) application for FTX-6058 for the potential treatment of